34 research outputs found
Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant
[No abstract available
PHASE I STUDY OF SINGLE ASCENDING DOSES OF BEFLOXATONE, A NEW REVERSIBLE MAO-A INHIBITOR ANTIDEPRESSANT
peer reviewe